Salbupart
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The studies material comprised 10 placentae from pregnancies at risk for premature labour with delayed intrauterine growth of the…
Conclusions1.It has been shown experimentally and clinically that salbupart possesses a marked inhibitory action on uterine…
The purpose of the study was determination of the perfusion pressure as an expression of the resistance of placental vascular bed…
The effect of tocolytic treatment with Salbupart and Partusisten in imminent premature labour on the serum levels of insulin…
Clinical and experimental studies have revealed that salbupart, a beta-mimetic agent, administered in a dose of 0.14 mg/kg (the…
Comparative trials of two tocolytic preparations, salbupart (Polfa) and partusisten, showed their high efficacy (75 and 80 per…